The application of guanabenz in a mouse model of ALS resulted in disease progression despite promoting the viability of fibroblasts expressing the disease-causing G93A mutant SOD1 protein under tunicamycin-induced ER stress conditions [175]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.